Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Opko Health, Inc.

NASDAQ: OPK · Life Sciences · 5 alerts · CIK 944809

Share price
$1.62Close, Nov 16
Market cap
$1.2B
Shares outstanding
742.51MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Opko Health, Inc. filings on SEC EDGAR ↗

4:08 PM ET 8-K
Divestiture

Opko Health Divestiture to Laboratory Corporation of America Holdings for $722M

OPKO Health and its subsidiary BioReference Health entered into a definitive agreement to sell certain assets of their clinical and anatomic pathology laboratory testing business to Labcorp for $722 million in cash. The deal includes clinical and women’s health testing, urology, and the proprietary 4Kscore prostate cancer test, with OPKO eligible for up to an additional $150 million in milestone payments over ten years based on 4Kscore revenue. The transaction is subject to HSR Clearance and customary closing conditions, with a target completion date by April 14, 2027.

Value
$722M
Counterparty
Laboratory Corporation of America Holdings
Term
up to 10 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.